Reece Tomlinson, CEO of Uvence, has explained the journey of launching a business during the Coronavirus crisis.
“This period has been a challenge for businesses across the world in a variety of sectors, but few have been hit as hard as non-essential cosmetic procedures. Launching a new business during this time has been a challenge but it has also presented a number of exciting opportunities in a new environment.
We have had to adapt our launch by extending our waiting list, redressing the surgery with COVID-friendly Personal Protective Equipment and hosting initial video consultation pre-operation rather than in person. This is a new norm that we have been able to quickly pivot towards, unlike larger, less mobile and more established clinics, meaning we can offer treatments more tailored to our clients’ needs in the medium and long-term and not just during COVID-19.
Our research indicates that the demand for cosmetic surgery will continue to grow, as we have observed a considerable increase in popularity in recent years. Two key components in the development of cosmetic surgery are to make the procedures less invasive and more affordable, but the recent boom in popularity of treatments such as dermal fillers, micro-liposuction and facelifts has also come with a reliance on these procedures as quick fixes for body-image issues, which can obviously be problematic. This pause for the industry is likely to make many surgeons and firms take stock of what they are currently doing and the kind of treatments they are going to offer in five, ten, fifteen years. “